EDAP TMS SA Reports Record HIFU Revenue for 2024
Ticker: EDAP · Form: 6-K · Filed: Mar 27, 2025 · CIK: 1041934
| Field | Detail |
|---|---|
| Company | Edap Tms SA (EDAP) |
| Form Type | 6-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | bullish |
Sentiment: bullish
Topics: earnings, revenue-growth, medical-devices
TL;DR
EDAP TMS SA crushed 2024 HIFU revenue targets, hitting $25.7M full year and $9.3M in Q4!
AI Summary
EDAP TMS SA reported record High-Intensity Focused Ultrasound (HIFU) revenue for both the fourth quarter and full year of 2024. Full-year 2024 HIFU revenue reached USD 25.7 million, a 15.3% increase from 2023, while Q4 2024 HIFU revenue was USD 9.3 million, up 15.0% year-over-year. The report was filed on March 27, 2025.
Why It Matters
This filing indicates strong growth in EDAP's HIFU business, suggesting increasing adoption and market traction for their technology in the electromedical sector.
Risk Assessment
Risk Level: low — The filing is a routine financial results report with no new material adverse information.
Key Numbers
- USD 25.7M — Full-Year 2024 HIFU Revenue (Represents a 15.3% increase over 2023, indicating strong annual growth.)
- USD 9.3M — Q4 2024 HIFU Revenue (Represents a 15.0% increase over Q4 2023, showing continued quarterly momentum.)
Key Players & Entities
- EDAP TMS SA (company) — Filer of the report and subject of the results
- USD 25.7 million (dollar_amount) — Record full-year 2024 HIFU revenue
- USD 9.3 million (dollar_amount) — Record Q4 2024 HIFU revenue
- March 27, 2025 (date) — Filing date of the report
- KEN MOBECK (person) — Chief Financial Officer who signed the report
FAQ
What specific products or services contributed to the record HIFU revenue?
The filing does not specify which HIFU products or services drove the record revenue, only the overall HIFU revenue figures.
What is the outlook for HIFU revenue in 2025?
This report does not provide forward-looking guidance or an outlook for 2025 revenue.
What was the total revenue for EDAP TMS SA in 2024?
The filing only reports HIFU revenue and does not provide the company's total revenue for 2024.
Who is Ken Mobek?
Ken Mobek is the Chief Financial Officer of EDAP TMS SA and signed the report on March 27, 2025.
What is the significance of the 15.3% and 15.0% increases in HIFU revenue?
These percentage increases indicate significant year-over-year and quarter-over-quarter growth in the company's High-Intensity Focused Ultrasound business segment.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 27, 2025 by KEN MOBECK regarding EDAP TMS SA (EDAP).